The increase includes greater spending on Alzheimer's disease research, precision medicine, and cancer research initiatives.
The Bidens have convened a diverse board and staff with the goal of continuing efforts to accelerate research and development begun under the Cancer Moonshot Initiative.
President Trump had previously asked Collins to remain NIH director on a temporary basis.
Entering a new chapter with a new leader, ACLA lends support to a draft bill that would regulate lab tests not as medical devices but as in vitro clinical tests.
In his budget plan for fiscal 2018, President Trump is seeking to trim nearly $6 billion from the NIH's budget.
President Trump had previously called for a $1.2 billion reduction in the NIH's budget for the remainder of the fiscal year.
The Ventana PD-L1 assay was approved as a complementary diagnostic for bladder cancer patients being considered for treatment with the immunotherapy Imfinzi.
The omnibus spending bill, which has garnered bipartisan support, follows the White House's call to trim the NIH budget by $1.2 billion.
S.794 would require Medicare contractors to hold public meetings and disclose the rationale and evidence underlying an LCD at the start of the process.
The proposed cut comes on the heels of a budget proposal that would reduce the NIH's fiscal year 2018 budget by 20 percent.
The draft bill, based on a proposal developed by a coalition of Dx manufacturers and labs, would split oversight responsibilities across the FDA, CMS, and states.
Enrolling more participants from groups underrepresented in biomedical research is a laudable goal, but the current administration's policies may make it hard to achieve.
In his report, President Trump called for a reduction in National Institutes of Health funding, along with a reorganization of the agency.
Any short-term gains the bill may have on encouraging healthier lifestyles wouldn’t be worth the crippling effects it could have on the genomics field, leaders in the space said.
Some 50 groups have signed a letter expressing strong opposition to a bill that would allow workplace wellness programs to collect employees' genetic information.
The authors framed their report as a guidebook to help regulatory agencies across the globe coordinate "consistent" rules while allowing for societal differences.
Researchers fear the executive order will have long-lasting effects on the US' ability to recruit top talent, and will make the country less attractive as an international conference venue.
The organization cited ethical concerns and technological limitations surrounding CRISPR and other gene-editing approaches.
The agency expects existing programs to guide its regulation, adding that modified portions of animal genomes would be considered drugs.
The Genomics Evidence Neoplasia Information Exchange aims to provide insights through the analysis of data from tens if not hundreds of thousands of patient results.
Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.
A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.
In Science this week: CRISPR-based approach for recording cellular events, and more.
A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.